AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 144 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $221 | +268.3% | 52,455 | +21.2% | 0.00% | +200.0% |
| Q1 2023 | $60 | -100.0% | 43,282 | -30.5% | 0.00% | -50.0% |
| Q3 2022 | $126,000 | +70.3% | 62,243 | +300.4% | 0.00% | – |
| Q4 2021 | $74,000 | -64.6% | 15,547 | -60.3% | 0.00% | -100.0% |
| Q3 2021 | $209,000 | +80.2% | 39,120 | +127.8% | 0.00% | 0.0% |
| Q1 2021 | $116,000 | +34.9% | 17,170 | -9.0% | 0.00% | – |
| Q4 2020 | $86,000 | -68.8% | 18,876 | -67.4% | 0.00% | -100.0% |
| Q2 2020 | $276,000 | +93.0% | 57,907 | +40.6% | 0.00% | +100.0% |
| Q1 2020 | $143,000 | +95.9% | 41,196 | +170.6% | 0.00% | 0.0% |
| Q4 2019 | $73,000 | +135.5% | 15,224 | +40.4% | 0.00% | – |
| Q3 2019 | $31,000 | -98.4% | 10,844 | -95.9% | 0.00% | -100.0% |
| Q2 2019 | $1,906,000 | +892.7% | 265,834 | +1776.4% | 0.01% | +550.0% |
| Q4 2018 | $192,000 | +60.0% | 14,167 | +93.0% | 0.00% | +100.0% |
| Q2 2018 | $120,000 | – | 7,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $102,442,000 | 9.84% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $77,176,000 | 1.36% |
| Sivik Global Healthcare LLC | 600,000 | $2,856,000 | 0.95% |
| THB ASSET MANAGEMENT | 651,150 | $3,099,000 | 0.90% |
| Eversept Partners, LP | 886,587 | $4,220,154 | 0.58% |
| Spark Investment Management LLC | 30,100 | $143,000 | 0.52% |
| GLOBEFLEX CAPITAL L P | 240,680 | $1,146,000 | 0.29% |
| Alambic Investment Management, L.P. | 19,493 | $93,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 49,901 | $238,000 | 0.13% |
| C M BIDWELL & ASSOCIATES LTD | 29,550 | $141,000 | 0.13% |